36
Participants
Start Date
July 1, 2024
Primary Completion Date
March 25, 2025
Study Completion Date
March 25, 2025
delta-9-tetrahydrocannabinol (THC) (5)
5 mg of THC
Placebo
Placebo - dextrose
delta-9-tetrahydrocannabinol (THC) (10)
10 mg of THC
University of Chicago, Chicago
University of Chicago
OTHER